These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Pharmacologic profile of a new antiallergic compound PRD-92-Ea. El-Azab J, Stewart PB. Int Arch Allergy Appl Immunol; 1977 Mar; 55(1-6):350-61. PubMed ID: 73514 [Abstract] [Full Text] [Related]
3. In vitro antagonism of the mediators of allergy by a benzopyrano-benzopyran carboxylic acid PR-D-92-EA. Possanza GJ, Bauen A, Stewart PB. Int Arch Allergy Appl Immunol; 1975 Mar; 49(6):789-95. PubMed ID: 336 [Abstract] [Full Text] [Related]
4. Anti-allergic properties of a new coumarin compound (BM 15,100) [proceedings]. Roesch A, Roesch E. Br J Pharmacol; 1976 Jul; 57(3):438P. PubMed ID: 10033 [No Abstract] [Full Text] [Related]
5. Antiallergic 9-oxo-11-hydroxy-5H,9H-[2]benzopyrano[4,3-g][1]benzopyrans. Devlin JP, Bauen A, Possanza GJ, Stewart PB. J Med Chem; 1978 May; 21(5):480-3. PubMed ID: 660595 [Abstract] [Full Text] [Related]
6. Studies on antianaphylactic agents. 7. Synthesis of antiallergic 5-oxo-5H-[1]benzopyrano[2,3-b]pyridines. Nohara A, Ishiguro T, Ukawa K, Sugihara H, Maki Y, Sanno Y. J Med Chem; 1985 May; 28(5):559-68. PubMed ID: 3989816 [Abstract] [Full Text] [Related]
7. Synthesis and structure-activity relationships of 5H,11 H-[I]benzopyrano[4,3-g]benzopyran-9-carboxylic acids. Devlin JP, Freter K, Stewart PB. J Med Chem; 1977 Feb; 20(2):205-9. PubMed ID: 836491 [Abstract] [Full Text] [Related]
8. Profiles of different anti-allergy effects of a new histamine antagonist, BM 15,100 [proceedings]. Assem ES, Chong EK. Br J Pharmacol; 1976 Jul; 57(3):437P-438P. PubMed ID: 10032 [No Abstract] [Full Text] [Related]
9. Anti-allergy properties of PRD-92 Ea in guinea pig and rat. Beets JL, Meade HM, Morley J. Int Arch Allergy Appl Immunol; 1980 Jul; 61(4):449-56. PubMed ID: 6444926 [Abstract] [Full Text] [Related]
10. Studies on the mechanism of action by which 5H-[1]-benzopyrano-[2,3,-b]-pyridin-5-ol (AH 6696) inhibits gastric acid secretion [proceedings]. Ashby P, Curwain BP, Daly MJ, McIsaac RL. Br J Pharmacol; 1976 Jul; 57(3):440P-441P. PubMed ID: 974337 [No Abstract] [Full Text] [Related]
11. Synthesis and pharmaceutical activity of new series of chromonyl derivatives. Fawzy NM, Swelam SA, Batran SA. Boll Chim Farm; 2004 Jul; 143(1):24-33. PubMed ID: 15085572 [Abstract] [Full Text] [Related]
12. Pharmacology of the specific histamine H1-antagonist astemizole. Awouters FH, Niemegeers CJ, Janssen PA. Arzneimittelforschung; 1983 Jul; 33(3):381-8. PubMed ID: 6135428 [No Abstract] [Full Text] [Related]
13. [Pharmacologic properties of the antihistiminic 1-dimethylaminoethyl-2-alpha-pyridyl-4-oxo-1,2,3,4-tetrahydroquinazoline]. Muacević G, Stötzer H, Wick H. Arzneimittelforschung; 1965 Jun; 15(6):613-8. PubMed ID: 4380237 [No Abstract] [Full Text] [Related]
14. Pharmacological treatment of allergies. De Vos C. Allerg Immunol (Paris); 1992 Dec; 24(10):382-4. PubMed ID: 1363195 [Abstract] [Full Text] [Related]
15. New basic esters of 2-phenyl-3-methyl-4-oxo-4H-1-benzopyran-8-carboxylic acid endowed with spasmolytic properties. Synthesis and pharmacological-pharmacokinetic evaluation. Nardi D, Leonardi A, Pennini R, Tajana A, Cazzulani P, Testa R. Arzneimittelforschung; 1993 Jan; 43(1):28-34. PubMed ID: 8447843 [Abstract] [Full Text] [Related]
16. Differences in toxicity due to species variation in the metabolism of an oral anti-allergy agent [proceedings]. Smith DA. Br J Pharmacol; 1979 Jul; 66(3):422P-423P. PubMed ID: 43174 [No Abstract] [Full Text] [Related]
17. Antiallergy activity of Sch 37224, a new inhibitor of leukotriene formation. Kreutner W, Sherwood J, Sehring S, Rizzo C, Chapman RW, Siegel MI, Egan RW. J Pharmacol Exp Ther; 1988 Dec; 247(3):997-1003. PubMed ID: 2462630 [Abstract] [Full Text] [Related]
18. The gastrointestinal absorption of PRD-92 Ea, a new anti-allergy drug. Johnson AJ, Beets JL. Br J Clin Pharmacol; 1979 May; 7(5):511-3. PubMed ID: 38823 [Abstract] [Full Text] [Related]
19. Proceedings: Anti-inflammatory activity of 2-(5H-(1)benzopyrano(2,3-b) pyridin-7-yl) propionic acid (Y-8004). Nakanishi M, Maruyama Y, Terasawa M, Anami K. Jpn J Pharmacol; 1974 May; 24(0):s:140. PubMed ID: 4545994 [No Abstract] [Full Text] [Related]
20. 3,4-dihydro-2, 2-dimethyl-H-1 benzopyran-6-butyric acid. Its preparation from zanthoxylol and its antiinflammatory and related pharmacological properties. Okpako DT, Oriowo MA, Okogun JI, Ekong DE, Enyenihi VU. Planta Med; 1983 Feb; 47(2):112-6. PubMed ID: 6844451 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]